Home > Resources > Whitepapers > Patient-Centered Care in Type 2 Diabetes Mellitus

Patient-Centered Care in Type 2 Diabetes Mellitus

March 29, 2018

There have been many advancements in pharmacologic agents for the treatment of type 2 diabetes mellitus (T2DM) during the past 3 decades. At the same time, evidence in support of interventional approaches, the relationship between clinical parameters and chronic complications, and effective self-management behaviors has grown exponentially and has informed providers and patients of effective strategies for controlling blood glucose and other risk factors to minimize the risk of complications.

Spotlight

St. Michael's Hospital

St. Michael’s Hospital provides compassionate care to all who enter its doors. The hospital also provides outstanding medical education to future health care professionals in 27 academic disciplines. Critical care and trauma, heart disease, neurosurgery, diabetes, cancer care, care of the homeless and global health are among the hospital’s recognized areas of expertise. Through the Keenan Research Centre and the Li Ka Shing International Healthcare Education Centre, which make up the Li Ka Shing Knowledge Institute, research and education at St. Michael's Hospital are recognized and make an impact around the world. Founded in 1892, the hospital is fully affiliated with the University of Toronto.

OTHER WHITEPAPERS

2022 Over-the-counter Item Catalog

whitePaper | November 24, 2022

Please keep this valuable booklet nearby. You’ll need it to look up the OTC items you want to order.

As patient care channels become more fragmented, communications & coordination can become integrated

whitePaper | June 30, 2022

A platform approach to clinical communications keeps clinicians connected and patient data more secure

How Intelligent Workflow Technology Can Help Address Surgeons' Top Documentation Burdens

whitePaper | March 8, 2023

Surgical documentation practices are continuously evolving. In the last several years, surgeons have transitioned from heavy reliance on transcription technologies to EHR templates and advanced technology solutions to handle most of their documentation needs.

Planning your first-in-human trial

whitePaper | June 24, 2023

A first-in-human (FIH) clinical trial is a significant milestone in the development of a potential new drug in that it will be the first opportunity for a drug development sponsor to evaluate the impact of their new chemical entity (NCE) or biologic in humans.

Using Clinical Trial Sites’Input to Select the Right Capabilities when Decentralizing Clinical Trials

whitePaper | March 22, 2023

The COVID-19 pandemic has renewed emphasis on innovations to support clinical trial operations. Traditional sites including hospitals and private practices were forced during the height of the pandemic to find novel ways to continue patient care.

8 Reasons Why the Modern Provider Needs a Data Activation Platform

whitePaper | February 15, 2022

Every provider wants to innovate to drive transformation that helps reduce variability, improve efficiency, and support optimal patient care. The question is, how disruptive, in a positive sense, is your innovation? Most innovations in provider organizations are, in truth, iterative tweaks. While tweaks are the cornerstone of continuous improvement lifecycles, iteration isn’t the kind of transformation needed in healthcare. Real innovation creates a disruptive solution that fundamentally changes how people and processes work together, for the better.

Patient-Centered Care in Type 2 Diabetes Mellitus